Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (331-340 of 561) with videos related to

Pageof 57
Sort By:
European Urology|October 22, 2018
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic BiopsiesGiorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al.
European Urology Oncology|December 13, 2021
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary TumorsChiara Lonati, Andrea Necchi, Juan Gómez Rivas, et al.
European Urology Focus|June 27, 2024
The Impact of Second Opinion Expert Pathology Review in Patient Management at the Time of Transurethral Resection of the BladderDaniele Robesti, Marco Moschini, Nazario Pio Tenace, et al.
Clinical Genitourinary Cancer|October 13, 2020
The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC)Beat Foerster, Mohammad Abufaraj, Andrea Mari, et al.
World Journal of Urology|March 20, 2025
Comparison of extended and standard lymph node dissection in radical cystectomy for urothelial bladder cancer: a systematic review and meta-analysisAleksander Ślusarczyk, Pietro Scilipoti, Gautier Marcq, et al.
European Urology Oncology|April 12, 2025
Impact of Histological Subtypes/Divergent Differentiation on Clinicopathological and Oncological Outcomes for Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy: A Comprehensive Updated Systematic Review and Meta-analysisWojciech Krajewski, Łukasz Nowak, Jan Łaszkiewicz, et al.
Minerva Urology and Nephrology|April 23, 2026
Detrimental effect of delayed or incomplete BCG protocols administration after trans-urethral tumor resection in patients with non-muscle-invasive bladder cancer: a systematic reviewEttore DI Trapani, Arturo Lo Giudice, Elio Mazzone, et al.
European Urology Focus|March 25, 2021
Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease RecurrenceEkaterina Laukhtina, Mohammad Abufaraj, Abdallah Al-Ani, et al.
Minerva Urology and Nephrology|June 14, 2023
Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomyDavid D'Andrea, Shahrokh F Shariat, Francesco Soria, et al.
Diagnostics (Basel, Switzerland)|May 13, 2026
Beyond One-Size-Fits-All Active Surveillance for Low-Risk Prostate Cancer: Risk-Adapted Follow-Up, De-Escalation Pathways, and Focal Therapy as Tailored StrategyFabio Zattoni, Andrea Mari, Ugo Giovanni Falagario, et al.
Pageof 57

Showing results (331-340 of 561) with videos related to

Sort By:
Pageof 57
European Urology|October 22, 2018
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic BiopsiesGiorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al.
European Urology Oncology|December 13, 2021
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary TumorsChiara Lonati, Andrea Necchi, Juan Gómez Rivas, et al.
European Urology Focus|June 27, 2024
The Impact of Second Opinion Expert Pathology Review in Patient Management at the Time of Transurethral Resection of the BladderDaniele Robesti, Marco Moschini, Nazario Pio Tenace, et al.
Clinical Genitourinary Cancer|October 13, 2020
The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC)Beat Foerster, Mohammad Abufaraj, Andrea Mari, et al.
World Journal of Urology|March 20, 2025
Comparison of extended and standard lymph node dissection in radical cystectomy for urothelial bladder cancer: a systematic review and meta-analysisAleksander Ślusarczyk, Pietro Scilipoti, Gautier Marcq, et al.
European Urology Oncology|April 12, 2025
Impact of Histological Subtypes/Divergent Differentiation on Clinicopathological and Oncological Outcomes for Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy: A Comprehensive Updated Systematic Review and Meta-analysisWojciech Krajewski, Łukasz Nowak, Jan Łaszkiewicz, et al.
Minerva Urology and Nephrology|April 23, 2026
Detrimental effect of delayed or incomplete BCG protocols administration after trans-urethral tumor resection in patients with non-muscle-invasive bladder cancer: a systematic reviewEttore DI Trapani, Arturo Lo Giudice, Elio Mazzone, et al.
European Urology Focus|March 25, 2021
Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease RecurrenceEkaterina Laukhtina, Mohammad Abufaraj, Abdallah Al-Ani, et al.
Minerva Urology and Nephrology|June 14, 2023
Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomyDavid D'Andrea, Shahrokh F Shariat, Francesco Soria, et al.
Diagnostics (Basel, Switzerland)|May 13, 2026
Beyond One-Size-Fits-All Active Surveillance for Low-Risk Prostate Cancer: Risk-Adapted Follow-Up, De-Escalation Pathways, and Focal Therapy as Tailored StrategyFabio Zattoni, Andrea Mari, Ugo Giovanni Falagario, et al.
Pageof 57